Preventive effect of goshajinkigan on paclitaxel-induced peripheral neuropathy: an open-label, randomized phase II study (OLCSG2101).

Tanaka T, Makimoto G, Nakamura N, Kato Y, Oze I, Yokoyama T, Kuyama S, Senoo S, Inoue K, Ichikawa H, Maeda Y, Togashi Y, Hotta K

Open source

DOI
10.1093/oncolo/oyag352
Published
2026 Sep 16
Container
The oncologist
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/oncolo/oyag352,
  title = {Preventive effect of goshajinkigan on paclitaxel-induced peripheral neuropathy: an open-label, randomized phase II study (OLCSG2101).},
  author = {Tanaka T and Makimoto G and Nakamura N and Kato Y and Oze I and Yokoyama T and Kuyama S and Senoo S and Inoue K and Ichikawa H and Maeda Y and Togashi Y and Hotta K},
  year = {2026},
  journal = {The oncologist},
  doi = {10.1093/oncolo/oyag352},
  url = {https://doi.org/10.1093/oncolo/oyag352}
}

RIS

TY  - JOUR
TI  - Preventive effect of goshajinkigan on paclitaxel-induced peripheral neuropathy: an open-label, randomized phase II study (OLCSG2101).
AU  - Tanaka T
AU  - Makimoto G
AU  - Nakamura N
AU  - Kato Y
AU  - Oze I
AU  - Yokoyama T
AU  - Kuyama S
AU  - Senoo S
AU  - Inoue K
AU  - Ichikawa H
AU  - Maeda Y
AU  - Togashi Y
AU  - Hotta K
PY  - 2026
JO  - The oncologist
DO  - 10.1093/oncolo/oyag352
UR  - https://doi.org/10.1093/oncolo/oyag352
ER  - 

APA

T, T., G, M., N, N., Y, K., I, O., T, Y., S, K., S, S., K, I., H, I., Y, M., Y, T., & K, H. (2026). Preventive effect of goshajinkigan on paclitaxel-induced peripheral neuropathy: an open-label, randomized phase II study (OLCSG2101).. The oncologist. https://doi.org/10.1093/oncolo/oyag352

Source records